Medtronic plc.

Open: 83.44 Close: 83.57 Change: 0.13

Is Medtronic plc. Stock a good investment? This what an AI found.

The game is changing. There is a new strategy to evaluate Medtronic plc. fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, Medtronics, year, quarter, MDT, plc, company, …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Medtronic plc is an American medical device company. In 2023, Medtronics revenue was $31.23 billion, a decrease of -1.45% compared to the previous years. Board authorizes $5 billion for share purchase.

Today's News

Medtronic Plc (MDT) Stock News | Stock Titan. Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI. The expert summary details the impact and sentiment surrounding the news at the time of release. Medtronic plc is an American medical device company. In 2023, Medtronics revenue was $31.23 billion, a decrease of -1.45% compared to the previous years. Board authorizes $5 billion for share purchase. Medtronic has an earnings yield of 6.11% against the industrys yield of -0.72%. Medtronics global footprint, spanning more than 10,000 systems, is now more than four times greater than its nearest competitor owing to AiBLE. The board of directors approved the companys fourth quarter of fiscal year 2024 dividend on Thursday, March 7, 2024. Medtronic receives CE Mark for its next generation Micra leadless pacing systems. Board of directors of Medtronic plc (NYSE:MDT) approved the companys cash dividend for the third quarter of fiscal year 2024. A Kansas federal judge denied Medtronic request to strike purportedly false allegations in a qui tam suit alleging that Medtronics and its related company and a hospital violated the False Claims Act (FCA) The board of directors of Medtronronic plc (NYSE: MDT) on Thursday, March 7, 2024, approved the companys cash dividend for the fourth quarter of fiscal year 2024. The first faculty and staff group picture with the new Champ statue on campus was created by Minnesota-based sculptor Nick Legeros. Medtronic Inc(MDT-N) Rating Ranking : 4 out of 5 Bullish - Buy Buy Signals / Hold Signals. Buy 13   Hold 16   Sell 2 (Analysts price target is $89.74) Medtronic has exited the ventilator market to focus on higher acuity, hospital-based products. This strategic realignment emphasises Medtronics commitment to innovation. EP Wealth Advisors LLCs holdings in Medtronic were worth $1,595,000 at the end of the most recent reporting period. State Street Corp increased its position in shares of Medtronics by 0.3% during the second quarter. Morgan Stanley dropped their target price on Medtron from $104.00 to $98.00 and set an “overweight” rating. Ariel Mactavish, president of the Respiratory Interventions unit at Medtronic, announced that she is departing her post at the medtech giant. In a post on LinkedIn, she explained her decision to depart. Medtronic manufactures more than half of all pacemakers implanted worldwide. The company is traded under the ticker MDT on the NYSE exchange in Dublin, Ireland.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

How much time have you spent trying to decide whether investing in Medtronic plc.? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, Medtronics, year, quarter, MDT, plc, company, and the most common words in the summary are: medtronic, false, stock, value, title, mdt, important, . One of the sentences in the summary was: Board authorizes $5 billion for share purchase.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #false #stock #value #title #mdt #important.